Research | Collaborative Centre for Genomic Cancer Medicine

Meet our research groups

The Collaborative Centre for Genomic Cancer Medicine is a joint venture between the University of Melbourne and Peter MacCallum Cancer Centre, bringing both organisation’s world-leading experts in cancer, genomics, and precision medicine into a unified group.

Man standing in foreground with people working in lab behind

Understanding the role of epigenetic regulators in cancer biology.

Developing the workflows, infrastructure and standards enabling real time use of genomic data to transform clinical approaches to cancer.

Discovering the causes of colorectal cancer, reducing its incidence, and improving precision prevention.

Man sitting in front of group of scientists in discussion at large desk

Using personalised cancer genomics to decode the underlying drivers and therapeutic vulnerabilities of challenging cancers, developing new tools for diagnosis and surveillance.

Ensuring equitable, best-practice palliative care for people with advanced cancer and their families.

Man standing in front of large microscope

Translating molecular pathology into cancer diagnostics.

A multidisciplinary team conducting data-driven and evidence-based health services research to optimise equitable cancer care that reflects the needs and preferences of people affected by cancer.

Man standing in lab in front of team working at benches

Advancing knowledge of complex tumours to support targeted treatment design.

Group having discussion around table looking at brochures

Driving solutions for the early detection of cancer in primary care settings.

Man sitting in lab coat in front of team

Using genomics to guide the clinical management of rare and diagnostically challenging cancers.

Understanding the evolution of cancer through development of molecular biomarkers for clinical application, including early detection, risk stratification and disease monitoring.

Building a better understanding of blood cancers, so every patient receives an accurate diagnosis and effective treatment.

Deciphering genomic codes to predict prostate cancer behaviour, informing better diagnostic tools and treatment models.

Interrogating genome and transcriptome data to identify novel cancer biomarkers and create new diagnostic tools.

Reducing the burden of bowel cancer by understanding it’s causes, improving early detection, and increasing participation in life-saving screening programs.

Research at the Collaborative Centre for Genomic Cancer Medicine

Meet our research groups

Cancer Epigenetics Lab | Professor Mark Dawson

Genomics Platform Group | Professor Oliver Hofmann

Colorectal Oncogenomics Group | Associate Professor Daniel Buchanan

Clinical Cancer Genomics | Professor Sean Grimmond

Palliative Nexus | Professor Jennifer Philip

Translational and Diagnostic Pathology | Professor Stephen Fox

Cancer Health Services Research | Professor Gang Chen

PHANTOM Lab | Professor Frederic Hollande

Cancer in Primary Care | Professor Jon Emery

Rare Disease Oncogenomics Lab | Richard Tothill

Molecular Biomarkers and Translational Genomics | Sarah-Jane Dawson

Wilson Centre for Blood Cancer Genomics | Associate Professor Piers Blombery

Prostate Cancer Research Group | Professor Chris Hovens & Professor Niall Corcoran

Cancer Bioinformatics | Professor Lachlan Coin

Precision Prevention and Early Detection of Colorectal Cancer Group | Professor Mark Jenkins

Watch our seminars